Skip to content
OpenCapital
Get started

Oragenics OGEN Q1 2026 earnings

Reported May 8, 2026 · After market close

Diluted EPS-$0.51Beat by $89.49
EPS estimate-$90.00

Next report

Aug 11, 2026 (In 3 weeks)
EPS estimate-$72.00

Versus estimates

Diluted EPS

Q1 2026-$0.51Beat by $89.49
Q4 2025-$0.54Beat by $89.46Q3 2025-$1.96Q2 2025-$3.10Q1 2025-$3.60Q4 2024-$0.11

Ask the moment Oragenics reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Oragenics report Q1 2026 earnings?
Oragenics (OGEN) reported Q1 2026 earnings on May 8, 2026 after market close.
What were Oragenics's Q1 2026 revenue and EPS?
Oragenics reported diluted EPS of $-0.51 for Q1 2026.
Did Oragenics beat estimates in Q1 2026?
EPS beat the consensus estimate of $-90.00 by $89.49.
How did Oragenics's Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, diluted EPS grew 85.8% from $-3.60.
Where can I find Oragenics's Q1 2026 SEC filings?
You can read the 8-K earnings release (0001493152-26-021627) and the 10-Q periodic report (0001493152-26-021967) directly on SEC EDGAR. The filing index links above go to sec.gov.